Frontiers in sleep · 2025
Effects of complete home-based biofeedback therapy on insomnia disorders in patients with cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hasuo Hideaki, Mori Keita, Matsuoka Hiromichi, Shimazu Mariko, Shizuma Hisaharu, Morita Yukihiro, Ishikawa Hideki
Аннотация
BACKGROUND: Professional palliative care for patients with cancer focuses on symptom management.
METHODS: This exploratory, randomized controlled study was conducted to compare the effects of complete home-based heart rate variability biofeedback (HRV-BFB) using an estimation formula for resonance frequency in managing insomnia disorders among patients with cancer.
RESULTS: Only 28 patients were included from the initial enrollment of 30 patients from two study sites. Results showed that compared to the control group, the HRV-BFB group improved sleep efficiency from 82.0% (standard deviation: 9.1%) to 87.8% (standard deviation: 7.2%) (p < 0.001) and decreased use of sleeping medication from 88.2% (95% confidence interval, 73.6-95.8) to 51.5% (95% confidence interval, 41.8-61.1) (p < 0.001).
CONCLUSIONS: This suggests that complete home-based HRV-BFB using an estimation formula for resonance frequency may be a promising tool for treating insomnia disorders in patients with cancer, potentially improving sleep efficiency and decreasing reliance on sleep medications.
CLINICAL TRIAL REGISTRATION: UMIN 000046884. Registered February 11, 2022. https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000053496.
METHODS: This exploratory, randomized controlled study was conducted to compare the effects of complete home-based heart rate variability biofeedback (HRV-BFB) using an estimation formula for resonance frequency in managing insomnia disorders among patients with cancer.
RESULTS: Only 28 patients were included from the initial enrollment of 30 patients from two study sites. Results showed that compared to the control group, the HRV-BFB group improved sleep efficiency from 82.0% (standard deviation: 9.1%) to 87.8% (standard deviation: 7.2%) (p < 0.001) and decreased use of sleeping medication from 88.2% (95% confidence interval, 73.6-95.8) to 51.5% (95% confidence interval, 41.8-61.1) (p < 0.001).
CONCLUSIONS: This suggests that complete home-based HRV-BFB using an estimation formula for resonance frequency may be a promising tool for treating insomnia disorders in patients with cancer, potentially improving sleep efficiency and decreasing reliance on sleep medications.
CLINICAL TRIAL REGISTRATION: UMIN 000046884. Registered February 11, 2022. https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000053496.